tiprankstipranks
GlaxoSmithKline (GSK)
NYSE:GSK
US Market
GSK
GlaxoSmithKline
RESEARCH TOOLSreports

GlaxoSmithKline (GSK) Income Statement

5,216 Followers

GlaxoSmithKline Income Statement

Last quarter (Q4 2025), GlaxoSmithKline's total revenue was £8.62B, an increase of 6.17% from the same quarter last year. In Q4, GlaxoSmithKline's net income was £636.00M. See GlaxoSmithKline’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
£ 31.95B£ 31.38B£ 30.33B£ 29.32B£ 24.70B
Gross Profit
£ 23.18B£ 22.33B£ 21.76B£ 19.77B£ 16.53B
Operating Expenses
£ 16.17B£ 18.31B£ 15.02B£ 13.34B£ 12.18B
Depreciation and Amortization
£ 3.70B£ 2.55B£ 2.29B£ 2.15B£ 2.12B
EBITDA
£ 11.62B£ 6.67B£ 9.08B£ 8.60B£ 6.49B
Operating Income
£ 7.01B£ 4.02B£ 6.75B£ 6.43B£ 4.36B
Other Income/Expenses
£ 226.92M£ -544.00M£ -681.00M£ -805.00M£ -758.00M
Pretax Income
£ 7.24B£ 3.48B£ 6.06B£ 5.63B£ 3.60B
Net Income
£ 5.59B£ 2.58B£ 4.93B£ 14.96B£ 4.38B
Per Share Metrics
Basic EPS
£ 2.76£ 1.26£ 2.44£ 2.44£ 2.74
Diluted EPS
£ 2.72£ 1.24£ 2.40£ 2.40£ 2.70
Weighted Average Shares Outstanding
 2.03B 2.04B 2.03B 2.01B 1.60B
Weighted Average Shares Outstanding (Diluted)
 2.06B 2.07B 2.06B 2.04B 1.62B
Currency in GBP

GlaxoSmithKline Earnings and Revenue History